TY  - JOUR
T1  - Comparative Insights into NGS Platforms for Clinical Pharmacogenomics: Advantages, Limitations, and Workflow Strategies
A1  - Pawel Zielinski
A1  - Lukasz Wrona
A1  - Jan Kowalski
A1  - Krzysztof Adamski
JF  - Specialty Journal of Pharmacognosy, Phytochemistry, and Biotechnology
JO  - Spec J Pharmacogn Phytochem Biotechnol
SN  - 3062-441X
Y1  - 2025
VL  - 5
IS  - 1
DO  - 10.51847/UGeBkxKCYY
SP  - 220
EP  - 234
N2  - Pharmacogenomics (PGx) focuses on using genetic information to improve and personalize drug therapy. Many clinical centers have already begun incorporating pharmacogenetic testing into routine care. Next-generation sequencing (NGS) is becoming a more comprehensive, efficient, and cost-effective tool for PGx applications. This review outlines the key factors involved in using NGS to guide medication decisions in clinical settings. It examines both the benefits and the challenges associated with adopting NGS-based PGx testing. In addition, it describes the limitations of different NGS platforms and highlights practical strategies for establishing and managing these technologies in clinical practice.
UR  - https://galaxypub.co/article/comparative-insights-into-ngs-platforms-for-clinical-pharmacogenomics-advantages-limitations-and-fclzbcdok1vzsmx
ER  -